Oncology Historical Income Statement

TOIIW Stock

USD 0.02 0 26.85%

Historical analysis of Oncology Institute income statement accounts such as Gross Profit of 45 M, Other Operating Expenses of 263.4 M, Cost Of Revenue of 181.5 M or Total Operating Expenses of 81.9 M can show how well The Oncology Institute performed in making a profits. Evaluating Oncology Institute income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Oncology Institute's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining The Oncology Institute latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether The Oncology Institute is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in The Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

About Oncology Income Statement Analysis

The Oncology Institute Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Oncology Institute shareholders. The income statement also shows Oncology investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Oncology Institute Income Statement Chart

Interest Expense is likely to climb to about 7.1 M in 2024, despite the fact that Tax Provision is likely to grow to (84.5 K).

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Cost Of Revenue Reconciled Depreciation

Total Revenue

Total revenue comprises all receipts The Oncology Institute generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of The Oncology Institute minus its cost of goods sold. It is profit before Oncology Institute operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of The Oncology Institute. It is also known as Oncology Institute overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on The Oncology Institute income statement and represents the costs associated with goods and services Oncology Institute provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Oncology Institute's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into The Oncology Institute current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in The Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.Interest Expense is likely to climb to about 7.1 M in 2024, despite the fact that Tax Provision is likely to grow to (84.5 K).

	2021	2022	2023	2024 (projected)
Interest Expense	320K	4.1M	6.8M	7.1M
Depreciation And Amortization	3.3M	4.4M	5.9M	3.8M

Interest Expense Depreciation And Amortization

Oncology Institute income statement Correlations

	Tax Provision	Net Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses
Tax Provision		0.54	-0.73	-0.54	-0.62	-0.76	-0.78	-0.77	0.76	0.53	0.53	0.51	-0.75	-0.77	-0.75	0.53	-0.44	0.52	0.98	0.37
Net Interest Income	0.54		-0.83	-1.0	-0.78	-0.87	-0.88	-0.86	0.91	0.9	0.89	0.88	-0.86	-0.84	-0.81	0.9	-0.16	0.9	0.49	0.85
Depreciation And Amortization	-0.73	-0.83		0.81	0.84	0.99	0.97	0.98	-0.91	-0.78	-0.76	-0.74	0.99	0.95	1.0	-0.77	0.35	-0.76	-0.68	-0.55
Interest Expense	-0.54	-1.0	0.81		0.77	0.86	0.87	0.85	-0.91	-0.9	-0.89	-0.88	0.85	0.83	0.8	-0.9	0.17	-0.9	-0.49	-0.87
Selling General Administrative	-0.62	-0.78	0.84	0.77		0.87	0.9	0.91	-0.93	-0.58	-0.57	-0.54	0.87	0.95	0.84	-0.58	0.63	-0.57	-0.52	-0.44
Total Revenue	-0.76	-0.87	0.99	0.86	0.87		0.99	1.0	-0.94	-0.8	-0.79	-0.77	1.0	0.97	0.98	-0.79	0.36	-0.79	-0.7	-0.58
Gross Profit	-0.78	-0.88	0.97	0.87	0.9	0.99		1.0	-0.96	-0.77	-0.76	-0.73	0.99	0.99	0.97	-0.76	0.43	-0.76	-0.71	-0.57
Other Operating Expenses	-0.77	-0.86	0.98	0.85	0.91	1.0	1.0		-0.96	-0.77	-0.75	-0.73	0.99	0.99	0.98	-0.76	0.43	-0.75	-0.7	-0.55
Operating Income	0.76	0.91	-0.91	-0.91	-0.93	-0.94	-0.96	-0.96		0.78	0.77	0.75	-0.94	-0.96	-0.92	0.78	-0.47	0.77	0.69	0.68
Net Income From Continuing Ops	0.53	0.9	-0.78	-0.9	-0.58	-0.8	-0.77	-0.77	0.78		1.0	1.0	-0.81	-0.7	-0.76	1.0	0.18	1.0	0.56	0.91
Ebit	0.53	0.89	-0.76	-0.89	-0.57	-0.79	-0.76	-0.75	0.77	1.0		1.0	-0.79	-0.68	-0.75	1.0	0.2	1.0	0.56	0.91
Ebitda	0.51	0.88	-0.74	-0.88	-0.54	-0.77	-0.73	-0.73	0.75	1.0	1.0		-0.77	-0.66	-0.72	1.0	0.23	1.0	0.55	0.91
Cost Of Revenue	-0.75	-0.86	0.99	0.85	0.87	1.0	0.99	0.99	-0.94	-0.81	-0.79	-0.77		0.97	0.99	-0.8	0.34	-0.79	-0.7	-0.58
Total Operating Expenses	-0.77	-0.84	0.95	0.83	0.95	0.97	0.99	0.99	-0.96	-0.7	-0.68	-0.66	0.97		0.94	-0.69	0.54	-0.69	-0.69	-0.51
Reconciled Depreciation	-0.75	-0.81	1.0	0.8	0.84	0.98	0.97	0.98	-0.92	-0.76	-0.75	-0.72	0.99	0.94		-0.75	0.38	-0.74	-0.69	-0.54
Income Before Tax	0.53	0.9	-0.77	-0.9	-0.58	-0.79	-0.76	-0.76	0.78	1.0	1.0	1.0	-0.8	-0.69	-0.75		0.19	1.0	0.56	0.91
Total Other Income Expense Net	-0.44	-0.16	0.35	0.17	0.63	0.36	0.43	0.43	-0.47	0.18	0.2	0.23	0.34	0.54	0.38	0.19		0.19	-0.28	0.21
Net Income	0.52	0.9	-0.76	-0.9	-0.57	-0.79	-0.76	-0.75	0.77	1.0	1.0	1.0	-0.79	-0.69	-0.74	1.0	0.19		0.54	0.91
Income Tax Expense	0.98	0.49	-0.68	-0.49	-0.52	-0.7	-0.71	-0.7	0.69	0.56	0.56	0.55	-0.7	-0.69	-0.69	0.56	-0.28	0.54		0.38
Selling And Marketing Expenses	0.37	0.85	-0.55	-0.87	-0.44	-0.58	-0.57	-0.55	0.68	0.91	0.91	0.91	-0.58	-0.51	-0.54	0.91	0.21	0.91	0.38

Click cells to compare fundamentals

Oncology Institute Account Relationship Matchups

Oncology Institute income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Tax Provision	1.4M	(492.8K)	(671K)	(243K)	(89K)	(84.6K)
Net Interest Income	(3.4K)	(347.1K)	(320K)	(4.1M)	(7.3M)	(6.9M)
Depreciation And Amortization	2.9M	3.2M	3.3M	4.4M	5.9M	3.8M
Interest Expense	3.4K	347.1K	320K	4.1M	6.8M	7.1M
Selling General Administrative	29.6M	309.2K	83.4M	119.7M	115.3M	67.6M
Total Revenue	155.4M	187.5M	203.0M	252.5M	324.2M	226.6M
Gross Profit	29.9M	36.9M	40.8M	52.1M	59.6M	45.0M
Other Operating Expenses	158.0M	195.7M	248.9M	324.5M	401.3M	263.4M
Operating Income	(2.6M)	(8.2M)	(45.9M)	(72.0M)	(77.0M)	(73.2M)
Net Income From Continuing Ops	(4.0M)	(14.3M)	(10.9M)	152K	(75.3M)	(71.6M)
Ebit	(2.6M)	(14.5M)	(11.3M)	4.0M	(76.3M)	(72.5M)
Ebitda	307.1K	(11.3M)	(7.9M)	8.4M	(70.5M)	(66.9M)
Cost Of Revenue	125.5M	150.6M	162.2M	200.4M	264.7M	181.5M
Total Operating Expenses	32.6M	45.1M	86.7M	124.1M	136.6M	81.9M
Reconciled Depreciation	2.9M	3.2M	3.3M	4.4M	5.5M	3.8M
Income Before Tax	(2.6M)	(14.8M)	(11.6M)	1.9M	(83.1M)	(78.9M)
Total Other Income Expense Net	(3.4K)	(6.6M)	34.3M	81.9M	(6.1M)	(5.8M)
Net Income	(4.0M)	(14.3M)	(10.9M)	1.7M	(83.1M)	(78.9M)
Income Tax Expense	1.4M	(492.8K)	(671K)	247K	(36K)	(34.2K)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for Oncology Stock Analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Oncology Historical Income Statement

About Oncology Income Statement Analysis

Oncology Institute Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Cost Of Revenue

Oncology Institute income statement Correlations

Oncology Institute Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Oncology Institute income statement Accounts

Also Currently Popular

Additional Tools for Oncology Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Gross Profit
Ebit	+ 1.0	Net Income From Continuing Ops
Ebitda	+ 1.0	Net Income From Continuing Ops

Interest Expense	- 1.0	Net Interest Income
Total Operating Expenses	- 0.96	Operating Income
Operating Income	- 0.96	Other Operating Expenses
Operating Income	- 0.96	Gross Profit
Cost Of Revenue	- 0.94	Operating Income
Operating Income	- 0.94	Total Revenue